News
FDA OKs Pfizer's Lipitor for use in diabetics
Gerald Hurowitz, M.D.Published 28 September 20051 min read
Key points
- Pfizer Inc. said on Tuesday U.S. regulators have approved its blockbuster cholesterol drug Lipitor to reduce the risk of Stroke and Heart Attack in diabetic patients.
- Pfizer said the approval is for patients with type 2, or adult onset, diabetes who have no signs of Heart disease but have multiple risk factors for the condition.
- Common risk factors include High cholesterol, High Blood Pressure, a family history of Heart disease, Smoking and Obesity.
Pfizer Inc. said on Tuesday U.S. regulators have approved its blockbuster cholesterol drug Lipitor to reduce the risk of Stroke and Heart Attack in diabetic patients.
Pfizer said the approval is for patients with type 2, or adult onset, diabetes who have no signs of Heart disease but have multiple risk factors for the condition.
Common risk factors include High cholesterol, High Blood Pressure, a family history of Heart disease, Smoking and Obesity.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
